Ionis Pharmaceuticals, Inc.
Modulators of diacyglycerol acyltransferase 2 (DGAT2)
Last updated:
Abstract:
The present embodiments provide methods, compounds, and compositions useful for inhibiting DGAT2 expression, which may be useful for treating, preventing, or ameliorating a disease associated with DGAT2.
Status:
Grant
Type:
Utility
Filling date:
28 Jun 2019
Issue date:
26 Apr 2022